SLC6A3 and cardiac hypertrophy: Notably, DAT significantly reduced I/R‐induced cardiac hypertrophy, as indicated by the increased HW/BW and HW/TL ratios post‐I/R, which were reversed by DAT treatment (Figure 2C).